Veterinary Vaccines research report covers the Types of Veterinary Vaccines and the different Species for which Vaccines are present in the market. The Types of Veterinary Vaccines covered include Live Attenuated, Inactivated, Recombinant and Other (Conjugate Vaccines, DNA Vaccines, Toxoids etc). The Species include Bovine, Porcine, Poultry, Canine & Feline, Ovine & Caprine and Other (Equine, Fish, Wild Animals etc.). The study includes estimates and projections for the total global Veterinary Vaccines market and also key regional markets that include North America, Europe, Asia-Pacific Latin America, Middle East and Rest of World. Estimates and projections are illustrated graphically. Business profiles of 13 major companies are discussed in the research report. The research report serves as a guide to global Veterinary Vaccines industry, covering 248 companies that are engaged in the development and supply of Veterinary Vaccines. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report. Graphically illustrated exhibits (154) complements the market research report.

Free Sample Research Report

Download Table of contents

The potential of vaccines to improve efficiency of growth, immunity towards diseases, and to lower the rate of mortality has become a critical factor in prevention of diseases. The global Veterinary Vaccines market is rapidly growing at a CAGR of more than 6% and is projected to reach US$5.1 billion by the year 2012.
Europe is the leading market (almost 30% of global market share in 2006) for Veterinary Vaccines and is closely followed by North America. Europe is projected to manage the leading position throughout the analysis period with its share dropping to 28.8% by 2012. Due to high susceptibility to diseases and heavy demand, Asia-Pacific is the fastest growing (7.7% during 2005-2012) market for Veterinary Vaccines.
Major Vaccine Producers such as Virbac S.A (France), Intervet International BV (The Netherlands), Heska Corporation, Fort Dodge Animal Health (USA) Bayer Health Care AG (Germany), Merial Animal Health Ltd. (UK), Venkateshwara Hatcheries (India) allot vast resources to initiate and develop new technologies in vaccine delivery and immunological potency.

Continuous product innovation is necessary in order to keep pace with the changing disease patterns and animals developing resistance to available antimicrobials. Varied farming conditions and changing animal husbandry methods are resulting in the emergence of new or different disease problems.

-Bayer HealthCare AG (Germany)
-Fort Dodge Animal Health (USA)
-Heska Corporation (USA)
-Imugene Limited (Australia)
-Indian Immunologicals Ltd. (IIL) (India)
-Intervet International BV (The Netherlands)
-Merial Animal Health Ltd. (UK)
-Novartis International AG (Switzerland)
-Pfizer, Inc. (USA)
-Protein Sciences Corporation (USA)
-Schering-Plough Animal Health (USA)
-Venkateshwara Hatcheries Group (India)
-Virbac SA (France)

For those who are intrested to buy the report by chapter:

CHAPTER	TITLE	SHORT DESCRIPTION	PRICE (US$)
I	Scope and Methodology	This chapter provides information regarding the research methodology, limitations of the study, market measuring units and exchange rates used. * Will be delivered free with purchase of any of the other chapters mentioned below.	FREE*
II	Report Synopsis	Synopsis of the research report summarizes the global market of Veterinary Vaccines by Type and Species. Global market is also analyzed by geographic regions including North America, Europe, Asia-Pacific, Latin America, Middle East and Rest of World.	$1100
III	Product / Technology Research	This chapter gives an insight into the Veterinary Vaccines market including definitions, segmentation and applications. The chapter also provides market values in US$ (for the period 2005 through 2012). Global and regional markets are analyzed. The chapter also includes product trends, and potential opportunities.	$800
IV	Market Dynamics	Market Dynamics provides information on global markets for Veterinary Vaccines. The chapter includes global market analysis by geographic regions; analysis of each region by Type and by Species; a brief business profile of major global companies; and a glance at corporate activities such as mergers and acquisitions, partnerships, new product developments/launches etc. Also includes market trends and industry outlook.	$1900
V	Corporate Directory	This chapter provides the region-wise list of 248 companies, CROs, and Universities that are engaged in Veterinary Vaccines research, products and services market.	$300